Connection

Kit Simpson to Remission Induction

Back to Details
This is a "connection" page, showing publications Kit Simpson has written about Remission Induction.
Kit Simpson
Connection Strength
0.075
Remission Induction
  1. Cost-effectiveness of extended adjuvant rituximab for US patients aged 65-70 years with follicular lymphoma in second remission. Clin Lymphoma Myeloma. 2008 Jun; 8(3):166-70.
    View in: PubMed
    Score: 0.075
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.